{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:28:21Z","timestamp":1767846501102,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jjcc.2022.12.006","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:35:06Z","timestamp":1672313706000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan"],"prefix":"10.1016","volume":"82","author":[{"given":"Koichiro","family":"Kinugawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2022.12.006_bb0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0010","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0015","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure- digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the heart failure Association of the European Society of cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"Suppl. 1","key":"10.1016\/j.jjcc.2022.12.006_bb0030","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s10557-011-6304-x","article-title":"Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study)","volume":"25","author":"Matsuzaki","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0035","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1253\/circj.CJ-19-0158","article-title":"Real-world effectiveness and tolerability of tolvaptan in patients with heart failure- final results of the samsca post-marketing surveillance in heart failure (SMILE) study","volume":"83","author":"Kinugawa","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ehf2.13111","article-title":"Temporal trends of a vasopressin V(2) receptor antagonist in heart failure using a nationwide database in Japan","volume":"8","author":"Kuragaichi","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0045","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.jacc.2007.01.091","article-title":"Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction","volume":"49","author":"Udelson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0055","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1253\/circj.CJ-14-0244","article-title":"Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure","volume":"78","author":"Imamura","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207481","article-title":"A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan","volume":"13","author":"Takimura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5582\/ddt.2017.01018","article-title":"Experience with long-term administration of tolvaptan to patients with acute decompensated heart failure","volume":"11","author":"Kiuchi","year":"2017","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0070","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1253\/circj.CJ-17-0554","article-title":"Safety and efficacy of long-term use of tolvaptan in patients with heart failure and chronic kidney disease","volume":"81","author":"Uemura","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1536\/ihj.16-023","article-title":"Tolvaptan improves the long-term prognosis in patients with congestive heart failure with preserved ejection fraction as well as in those with reduced ejection fraction","volume":"57","author":"Imamura","year":"2016","journal-title":"Int Heart J"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0080","first-page":"59","article-title":"Efficacy of tolvaptan in elderly patients with heart failure and preserved ejection fraction","volume":"5","author":"Suzuki","year":"2019","journal-title":"J Cardiovasc Emerg"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ehf2.12418","article-title":"Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan","volume":"6","author":"Shiga","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0090","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1253\/circj.70.1617","article-title":"Clinical characteristics and outcome of hospitalized patients with heart failure in Japan","volume":"70","author":"Tsutsui","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0095","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1253\/circj.CJ-18-1087","article-title":"Prognostic impact of previous hospitalization in acute heart failure patients","volume":"83","author":"Akita","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1253\/circrep.CR-19-0064","article-title":"Long-term tolvaptan treatment in refractory heart failure","volume":"1","author":"Imamura","year":"2019","journal-title":"Circ Rep"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/hepr.13635","article-title":"Real-world hospital mortality of liver cirrhosis inpatients in Japan: a large-scale cohort study using a medical claims database: prognosis of liver cirrhosis","volume":"51","author":"Yatsuhashi","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jjcc.2018.10.003","article-title":"Update of acute and long-term tolvaptan therapy","volume":"73","author":"Imamura","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0115","doi-asserted-by":"crossref","first-page":"19L","DOI":"10.1016\/j.amjcard.2005.09.066","article-title":"Hyponatremia in patients with heart failure","volume":"96","author":"De Luca","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0120","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/archinte.167.18.1998","article-title":"Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial","volume":"167","author":"Gheorghiade","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0130","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0135","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0145","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-141-9-200411020-00011","article-title":"Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction","volume":"141","author":"Lee","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0150","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2022.12.006_bb0155","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1253\/circj.CJ-21-0431","article-title":"JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure","volume":"85","author":"Tsutsui","year":"2021","journal-title":"Circ J"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508722003239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508722003239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:08:17Z","timestamp":1760274497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508722003239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0914508722003239"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2022.12.006","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2022.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}